Perspective Therapeutics, Inc.

NYSEAM:CATX Stock Report

Market Cap: US$192.6m

Perspective Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:CATX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Dec 24BuyUS$30,132Johan SpoorIndividual8,000US$3.77
04 Dec 24BuyUS$100,004Heidi HensonIndividual25,975US$3.85
25 Nov 24BuyUS$48,974Jonathan HuntIndividual12,829US$3.94
17 Jun 24BuyUS$17,667Jonathan HuntIndividual1,800US$9.82
14 Jun 24BuyUS$499,900Lori Holmes-WoodsIndividual4,587US$109.00
13 Jun 24BuyUS$117,430Johan SpoorIndividual10,000US$11.74
03 Jun 24BuyUS$49,992Lori Holmes-WoodsIndividual3,424.6US$14.60
31 May 24BuyUS$75,900Robert WilliamsonIndividual5,500US$13.80
31 May 24BuyUS$35,007Jonathan HuntIndividual2,500.6US$14.00
29 May 24BuyUS$40,014Robert WilliamsonIndividual3,003.1US$13.40
06 Mar 24BuyUS$57,409,487Lantheus Holdings, Inc.Company6,043,103.9US$9.50
30 Jan 24BuyUS$90,710Robert WilliamsonIndividual12,720.6US$7.20
29 Jan 24BuyUS$78,474Robert WilliamsonIndividual13,587.9US$6.40
25 Jan 24BuyUS$25,478Robert WilliamsonIndividual5,199.6US$4.90
24 Jan 24BuyUS$139,888Markus PuhlmannIndividual28,000US$5.00
22 Jan 24BuyUS$20,846,671Lantheus Holdings, Inc.Company5,634,235.5US$3.70

Insider Trading Volume

Insider Buying: CATX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CATX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders3,471,4004.77%
Hedge Funds3,590,4264.93%
Private Companies4,343,0995.96%
Public Companies11,677,33916%
Institutions49,730,67168.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 140.9%.

Top Shareholders

Top 25 shareholders own 94.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.3%
Lantheus Holdings, Inc.
11,677,339US$33.3m0%no data
14.1%
FMR LLC
9,496,225US$27.1m72.5%no data
7.1%
Janus Henderson Group plc
4,799,352US$13.7m8%0.01%
5.98%
BlackRock, Inc.
4,039,974US$11.5m15.9%no data
5.31%
Avidity Partners Management, L.P.
3,590,426US$10.2m18.2%0.59%
4.96%
Commodore Capital LP
3,350,000US$9.5m-28.1%0.67%
4.55%
The Vanguard Group, Inc.
3,076,941US$8.8m5.33%no data
4.17%
Deerfield Management Company, L.P. Series C
2,817,763US$8.0m0%0.14%
3.99%
ASV-Viewpoint LLC
2,693,387US$7.7m0%no data
3.24%
State Street Global Advisors, Inc.
2,190,239US$6.2m120%no data
2.44%
Coleman 2022 Exempt Family Trust
1,649,712US$4.7m0%no data
2.37%
Nicholson Wealth Management Group, LLC
1,602,283US$4.6m0%4.49%
2.21%
Marshall Wace LLP
1,490,791US$4.2m16.1%0.01%
2.19%
Frances Johnson
1,483,466US$4.2m0%no data
2.19%
Michael Schultz
1,483,466US$4.2m0%no data
2.1%
Octagon Capital Advisors LP
1,422,224US$4.1m-10%0.67%
1.72%
Geode Capital Management, LLC
1,164,204US$3.3m12.5%no data
1.52%
Hills Bank and Trust Company, Asset Management Arm
1,027,830US$2.9m0%0.23%
1.36%
Paradigm Biocapital Advisors LP
919,692US$2.6m0%0.1%
1.22%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
822,471US$2.3m215%no data
1.11%
Adage Capital Management, L.P.
750,000US$2.1m96.5%no data
1.11%
Ghost Tree Capital, LLC
750,000US$2.1m-18.9%0.85%
0.98%
Columbia Management Investment Advisers, LLC
662,496US$1.9m7,010%no data
0.88%
Schonfeld Strategic Advisors LLC
591,623US$1.7m12.5%0.01%
0.87%
Sphera Funds Management Ltd
589,295US$1.7m-25.1%0.29%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 03:20
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Perspective Therapeutics, Inc. is covered by 14 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Alec StranahanBofA Global Research
Yuan ZhiB. Riley Securities, Inc.